The landscape of diabetes care is evolving with the emergence of skin-applied GLP-1 therapy. These convenient delivery systems offer a likely simpler alternative to needle administrations for individuals dealing with diabetes mellitus type 2 . Such a system deliver a GLP-1 agonist directly throug